Reaction: |
EC: |
Evidence: |
Physiological Direction: |
(5Z,8Z,11Z,14Z)-eicosatetraenoate + AH2 + 2 O2 = A + H2O + prostaglandin H2
|
1.14.99.1 |
PubMed:16373578, PubMed:22942274, PubMed:26859324, PubMed:27226593, PubMed:7592599, PubMed:7947975, PubMed:9261177 |
left-to-right |
(5Z,8Z,11Z,14Z)-eicosatetraenoate + 2 O2 = prostaglandin G2
|
- |
PubMed:22942274, PubMed:7592599, PubMed:7947975, PubMed:9261177 |
left-to-right |
PubMed:22942274, PubMed:7592599, PubMed:7947975, PubMed:9261177
|
AH2 + prostaglandin G2 = A + H2O + prostaglandin H2
|
- |
PubMed:22942274, PubMed:7592599, PubMed:7947975, PubMed:9261177 |
left-to-right |
(5Z,8Z,11Z,14Z,17Z)-eicosapentaenoate + 2 O2 = prostaglandin G3
|
- |
PubMed:19540099 |
left-to-right |
AH2 + prostaglandin G3 = A + H2O + prostaglandin H3
|
- |
PubMed:19540099 |
left-to-right |
(8Z,11Z,14Z)-eicosatrienoate + 2 O2 = prostaglandin G1
|
- |
PubMed:11939906 |
left-to-right |
AH2 + prostaglandin G1 = A + H2O + prostaglandin H1
|
- |
PubMed:11939906 |
left-to-right |
2-(5Z,8Z,11Z,14Z)-eicosatetraenoyl-sn-glycero-3- phosphoethanolamine + 2 O2 = 2-(prostaglandin G2)-sn-glycero-3- phosphoethanolamine
|
- |
PubMed:27642067 |
left-to-right |
2-(prostaglandin G2)-sn-glycero-3-phosphoethanolamine + AH2 = 2-(prostaglandin H2)-sn-glycero-3-phosphoethanolamine + A + H2O
|
- |
PubMed:27642067 |
left-to-right |
2-(5Z,8Z,11Z,14Z)-eicosatetraenoyl-sn-glycero-3-phosphocholine + 2 O2 = 2-(prostaglandin G2)-sn-glycero-3-phosphocholine
|
- |
PubMed:27642067 |
left-to-right |
2-(prostaglandin G2)-sn-glycero-3-phosphocholine + AH2 = 2- (prostaglandin H2)-sn-glycero-3-phosphocholine + A + H2O
|
- |
PubMed:27642067 |
left-to-right |
(15S)-hydroperoxy-(5Z,8Z,11Z,13E)-eicosatetraenoate + AH2 = (15S)-hydroxy-(5Z,8Z,11Z,13E)-eicosatetraenoate + A + H2O
|
- |
PubMed:9261177 |
left-to-right |
2-(5Z,8Z,11Z,14Z)-eicosatetraenoyl-sn-glycero-3-phosphocholine + AH2 + O2 = 2-[(15S)-hydroxy-(5Z,8Z,11Z,13E)-eicosatetraenoyl]-sn- glycero-3-phosphocholine + A + H2O
|
- |
PubMed:27642067 |
left-to-right |
2-(5Z,8Z,11Z,14Z)-eicosatetraenoyl-sn-glycero-3-phosphocholine + AH2 + O2 = 2-[(15R)-hydroxy-(5Z,8Z,11Z,13E)-eicosatetraenoyl]-sn- glycero-3-phosphocholine + A + H2O
|
- |
PubMed:27642067 |
left-to-right |
2-(5Z,8Z,11Z,14Z)-eicosatetraenoyl-sn-glycero-3-phosphocholine + AH2 + O2 = 2-[(11R)-hydroxy-(5Z,8Z,12E,14Z)-eicosatetraenoyl]-sn- glycero-3-phosphocholine + A + H2O
|
- |
PubMed:27642067 |
left-to-right |
(9Z,12Z)-octadecadienoate + AH2 + O2 = 9-hydroxy-(10E,12Z)- octadecadienoate + A + H2O
|
- |
PubMed:11034610, PubMed:11192938 |
left-to-right |
(9Z,12Z)-octadecadienoate + AH2 + O2 = 13-hydroxy-(9Z,11E)- octadecadienoate + A + H2O
|
- |
PubMed:11034610, PubMed:11192938 |
left-to-right |
(5Z,8Z,11Z,14Z)-eicosatetraenoate + AH2 + O2 = (15R)-hydroxy- (5Z,8Z,11Z,13E)-eicosatetraenoate + A + H2O
|
- |
PubMed:11034610, PubMed:11192938 |
left-to-right |
(5Z,8Z,11Z,14Z)-eicosatetraenoate + AH2 + O2 = (11R)-hydroxy- (5Z,8Z,12E,14Z)-eicosatetraenoate + A + H2O
|
- |
PubMed:11034610, PubMed:11192938 |
left-to-right |
(5Z,8Z,11Z,14Z,17Z)-eicosapentaenoate + AH2 + O2 = (11R)- hydroxy-(5Z,8Z,12E,14Z,17Z)-eicosapentaenoate + A + H2O
|
- |
PubMed:11034610, PubMed:11192938 |
left-to-right |
PubMed:11034610, PubMed:11192938
|
(5Z,8Z,11Z,14Z,17Z)-eicosapentaenoate + AH2 + O2 = (18S)- hydroxy-(5Z,8Z,11Z,14Z,16E)-eicosapentaenoate + A + H2O
|
- |
PubMed:21206090 |
left-to-right |
(5Z,8Z,11Z,14Z,17Z)-eicosapentaenoate + AH2 + O2 = (18R)- hydroxy-(5Z,8Z,11Z,14Z,16E)-eicosapentaenoate + A + H2O
|
- |
PubMed:11034610, PubMed:11192938, PubMed:21206090 |
left-to-right |
PubMed:11034610, PubMed:11192938, PubMed:21206090
|
(5Z,8Z,11Z,14Z,17Z)-eicosapentaenoate + AH2 + O2 = (15R)- hydroxy-(5Z,8Z,11Z,13E,17Z)-eicosapentaenoate + A + H2O
|
- |
PubMed:11034610, PubMed:11192938, PubMed:21206090 |
left-to-right |
PubMed:11034610, PubMed:11192938, PubMed:21206090
|
(5Z,8Z,11Z,14Z,17Z)-eicosapentaenoate + AH2 + O2 = (15S)- hydroxy-(5Z,8Z,11Z,13E,17Z)-eicosapentaenoate + A + H2O
|
- |
PubMed:21206090 |
left-to-right |
(7Z,10Z,13Z,16Z,19Z)-docosapentaenoate + AH2 + O2 = 13R- hydroxy-(7Z,10Z,14E,16Z,19Z)-docosapentaenoate + A + H2O
|
- |
PubMed:26236990 |
left-to-right |
(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoate + AH2 + O2 = 13- hydroxy-(4Z,7Z,10Z,14E,16Z,19Z)-docosahexaenoate + A + H2O
|
- |
PubMed:12391014 |
left-to-right |
(5S)-hydroxy-(6E,8Z,11Z,14Z)-eicosatetraenoate + AH2 + O2 = (5S,15R)-dihydroxy-(6E,8Z,11Z,13E)-eicosatetraenoate + A + H2O
|
- |
PubMed:22068350 |
left-to-right |
(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoate + AH2 + O2 = 17R- hydroxy-(4Z,7Z,10Z,13Z,15E,19Z)-docosahexaenoate + A + H2O
|
- |
PubMed:12391014 |
left-to-right |
(5S)-hydroxy-(6E,8Z,11Z,14Z)-eicosatetraenoate + AH2 + O2 = (5S,15S)-dihydroxy-(6E,8Z,11Z,13E)-eicosatetraenoate + A + H2O
|
- |
PubMed:22068350 |
left-to-right |
(5S)-hydroxy-(6E,8Z,11Z,14Z)-eicosatetraenoate + AH2 + O2 = (5S,11R)-dihydroxy-(6E,8Z,12E,14Z)-eicosatetraenoate + A + H2O
|
- |
PubMed:22068350, PubMed:26282205 |
left-to-right |
PubMed:22068350, PubMed:26282205
|
2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-glycerol + 2 O2 = 2- glyceryl-prostaglandin G2
|
- |
PubMed:22942274 |
left-to-right |
2-glyceryl-prostaglandin G2 + AH2 = 2-glyceryl-prostaglandin H2 + A + H2O
|
- |
PubMed:22942274 |
left-to-right |
(5Z,8Z,11Z,14Z)-eicosatetraenoate + O2 = (15R)-hydroperoxy- (5Z,8Z,11Z,13E)-eicosatetraenoate
|
- |
PubMed:9048568 |
left-to-right |
(5Z,8Z,11Z,14Z)-eicosatetraenoate + O2 = 11R-hydroperoxy- (5Z,8Z,12E,14Z)-eicosatetraenoate
|
- |
PubMed:9048568 |
left-to-right |
(9Z,12Z)-octadecadienoate + AH2 + O2 = (9R)-hydroxy-(10E,12Z)- octadecadienoate + A + H2O
|
- |
UniProtKB:P79208 |
left-to-right |
(9Z,12Z)-octadecadienoate + AH2 + O2 = (9S)-hydroxy-(10E,12Z)- octadecadienoate + A + H2O
|
- |
UniProtKB:P79208 |
left-to-right |
(9Z,12Z)-octadecadienoate + AH2 + O2 = (13S)-hydroxy-(9Z,11E)- octadecadienoate + A + H2O
|
- |
UniProtKB:P79208 |
left-to-right |
(9Z,12Z)-octadecadienoate + AH2 + O2 = (13R)-hydroxy-(9Z,11E)- octadecadienoate + A + H2O
|
- |
UniProtKB:P79208 |
left-to-right |
|